LCTX
Lineage Cell Therapeutics, Inc.
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Lineage Cell Therapeutics (LCTX) Stock: Buy, Sell, or Hold?
$1.02
-0.02 (-1.92%)
▼
5d:
-0.97%
30d:
+12.3%
90d:
-3.77%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
TODAY
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (51%)
Quality Score
59/100
Position
EXTENDED
30-Day Fair Range
$0.94 – $1.02
Position: EXTENDED
Forward P/E & Valuation
-7.6x
Next 12M consensus est.
Wall Street Target
$5.50
+428.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.96 / $1.09
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: LCTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When LCTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: LCTX is currently trading at $1.02, which is considered extended relative to its 30-day fair value range of $0.94 to $1.02.
Technical Outlook: Technically, LCTX is in a strong uptrend. Immediate support is located at $0.96, while resistance sits at $1.09.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.50 (+428.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LCTX is in a strong uptrend. Immediate support is located at $0.96, while resistance sits at $1.09.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.50 (+428.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.94 -
$1.02
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
Trading Range & Key Levels
30-Day Trading Range
$0.94 -
$1.02
Current vs Trading Range
EXTENDED
Support Level
$0.96
Resistance Level
$1.09
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 428.8% below Wall St target ($5.50)
- NEUTRAL: Bottoming setup forming (49/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-7.56
Wall Street Target
$5.50
(+428.8%)
Revenue Growth (YoY)
-61.3%
Profit Margin
-246.6%
Share LCTX Analysis
Share this live LCTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LCTX)
Bullish
4 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Investors on StockTwits express optimism about $LCTX following Roche's alleged investment in perfecting the ideal delivery device for the company's islet cells. Some traders anticipate major breakthroughs or deals.
Key Retail Themes:
Positive sentiment towards Roche's investment in $LCTX
Anticipation of major breakthroughs and deals
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 10:00 AM ET
Data refreshes hourly during market hours. Next update: 11:00 AM
Data refreshes hourly during market hours. Next update: 11:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LCTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 60 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 53 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 41 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LCTX Research Pages
